Skip to main content

NRC Health

corporate_fare Company Profile

NRC Health

NRC·NASDAQ·Industrial Applications And Services·CIK 0000070487

NRC Health provides analytics and insights to measure and improve patient and employee experience for healthcare organizations in the United States. The company offers several key solutions. Its market experience solutions are subscription-based services that track awareness, perception, and consistency of healthcare brands, assess differentiators, and provide segmentation tools to evaluate community needs, wants, and behaviors through assessments. Patient experience solutions include a cross-continuum multi-mode digital platform that collects and measures data to improve patient experience, engagement, and loyalty. Employee experience solutions combine healthcare with technology, covering engagement, pulse, lifecycle, culture of safety, and magnet RN satisfaction. Consumer experience solutions offer online reputation solutions, community insights, and cross-journey listening through nGage. Additionally, NRC Health provides Huey, an AI engine built for Human Understanding that serves as a healthcare experience management companion. Governance solutions are offered through national conferences, publications, advisory services, and an online portal for not-for-profit health system boards of directors, executives, and physician leadership. The company also provides services related to patient experience, service recovery, care transitions, employee engagement, reputation management, rounding, and brand loyalty. Founded in 1981, the company was formerly known as National Research Corporation and changed its name to NRC Health in April 2026. It is headquartered in Lincoln, Nebraska.

NRC Health (NASDAQ:NRC) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 23 items for NRC at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • NRC Health Reports Record $152M Total Recurring Contract Value, Up 13% Year-Over-Year
  • Major Shareholders Plan to Liquidate 14.5M Shares, Representing 64% of Outstanding Stock
  • National Research Corp Reports Significant Q4 and Full-Year 2025 Profitability Declines

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$137.39M
Net Income
$11.6M
Diluted EPS
$50.00
Op. Cash Flow
$26.45M
Free Cash Flow
$15.74M
Operating Income
$22.59M
Cash & Equivalents
$4.14M
Total Debt
$75.02M
Debt / Equity
5.36×
Net Margin
8.4%
Shares Outstanding
22.64M sh
Source: 10-K · filed 2026-04-28 · accession 0001437749-26-013686
$24.99
52-week range · as of 2026-11-06 $11.73 – $27.41
Market cap
$533.93M
Volume
88.9K (0.8× avg)
3-mo avg 105.6K
Live data · 2026-11-22 12:52 UTC · Market closed

show_chartPrice Chart

Loading chart...

feed NRC - Filings & News (Page 2)

NRC
Mar 04, 2026, 6:12 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $13.14
Real-time Price: $24.99 info
Change: +$11.85 (+90%) info
Market Cap: $533.934M info
NRC
Feb 10, 2026, 5:06 PM EST
Filing Type: 424B7
Importance Score:
9
Price at Filing: $14.56
Real-time Price: $24.99 info
Change: +$10.43 (+72%) info
Market Cap: $533.934M info
NRC
Feb 03, 2026, 9:06 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $21.00
Real-time Price: $24.99 info
Change: +$3.99 (+19%) info
Market Cap: $533.934M info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets